Skip to main content

Table 1 The clinicopathological characteristics among BCa patients

From: External validation of Pentafecta in patients undergoing laparoscopic radical cystectomy: results from a high-volume center

Characteristics Total Pentafecta attained Pentafecta not attained P value
Patients (n, %) 340 (100) 50 (14.7) 290 (85.4)  
Mean age, years ± SD 66.41 ± 11.27 62.64 ± 10.36 67.07 ± 11.31 0.01
Gender (n, %)     0.317
 Male 288 (84.7) 40 (80.0) 248 (85.5)  
 Female 52 (15.3) 10 (20.0) 42 (14.5)  
Smoking history (yes, %) 131 (38.5) 14 (28.0) 117 (40.3) 0.136
Neoadjuvant chemotherapy (n, %) 38 (11.2) 8 (16.0) 30 (10.3) 0.241
Type of urinary diversion (n, %)     0.014
 Cutaneous ureterostomy 173 (50.9) 16 (32.0) 157 (54.1)  
 Conduit 107 (31.5) 21 (42.0) 86 (29.7)  
 Orthotopic neobladder 60 (17.6) 13 (26.0) 47 (16.2)  
Pathological T-stage (%)     0.488
 pT0 29 (8.5) 1 (2.0) 28 (9.7)  
 pTa 25 (7.4) 3 (6.0) 22 (7.6)  
 pT1 96 (28.2) 17 (34.0) 79 (27.2)  
 pT2 83 (24.4) 12 (24.0) 71 (24.5)  
 pT3 65 (19.1) 9 (18.0) 56 (19.3)  
 pT4 42 (12.4) 8 (16.0) 34 (11.7)  
Pathological N-stage (%)     0.408
 N0 312 (91.8) 44 (88.0) 268 (92.4)  
 N1 15 (4.4) 4 (8.0) 11 (3.8)  
 N2 9 (2.6) 2 (4.0) 7 (2.4)  
 N3 4 (1.2) 0 (0) 4 (1.4)  
No. lymph node removed (mean, ± SD) 10.46 ± 8.60 20.34 ± 4.23 8.76 ± 8.0 < 0.001
  1. BCa = bladder cancer; SD = standard deviation